Analysis of Related Factors for Pathological Upgrading of Cervical Biopsy from CIN3 to Cancer After Conical Resection

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2024 Apr 2

PMID 38561685

Authors

Zhifang Li

Guiju Zhou

Longfan Jiang

Mengjie Wang

Affiliations

Soon will be listed here.

Abstract

Background: To investigate related factors for postoperative pathological upgrading of cervical biopsy to cervical cancer (CC) in patients with cervical intraepithelial neoplasia (CIN)3 after conical resection.

Methods: This retrospective study collected data from patients diagnosed with CIN3 by cervical biopsies at the author's Hospital between January 2012 and December 2022. The primary outcome was the pathological results of patients after conical resection. The pathological findings were categorized into the pathological upgrading group if postoperative pathology indicated CC, while those with normal, inflammatory, or cervical precancerous lesions were classified into the pathological non-upgrading group. The factors associated with upgrading were identified using multivariable logistic regression analysis.

Results: Among 511 patients, there were 125 patients in the pathological upgrading group (24.46%). The patients in the upgrading group were younger (47.68 ± 9.46 vs. 52.11 ± 7.02, P < 0.001), showed a lower proportion of menopausal women (38.40% vs. 53.02%, P = 0.0111), a lower proportion of HSIL (40.00% vs. 57.77%, P = 0.001), a higher rate of HPV-16/18 positive (25.60% vs. 17.36%, P = 0.011), a higher rate of contact bleeding (54.40% vs. 21.50%, P < 0.001), lower HDL levels (1.31 ± 0.29 vs. 1.37 ± 0.34 mmol/L, P = 0.002), higher neutrophil counts (median, 3.50 vs. 3.10 × 109/L, P = 0.001), higher red blood cell counts (4.01 ± 0.43 vs. 3.97 ± 0.47 × 1012/L, P = 0.002), higher platelet counts (204.84 ± 61.24 vs. 187.06 ± 73.66 × 109/L, P = 0.012), and a smaller platelet volume (median, 11.50 vs. 11.90 fL, P = 0.002).The multivariable logistic regression analysis showed that age (OR = 0.90, 95% CI: 0.86-0.94, P < 0.001), menopausal (OR = 2.68, 95% CI: 1.38-5.22, P = 0.004), contact bleeding (OR = 4.80, 95% CI: 2.91-7.91, P < 0.001), and mean platelet volume (OR = 0.83, 95% CI: 0.69-0.99, P = 0.038) were independently associated with pathological upgrading from CIN3 to CC after conical resection.

Conclusion: Age, menopausal, contact bleeding, and mean platelet volume are risk factors of pathological upgrading from CIN3 to CC after conical resection, which could help identify high risk and susceptible patients of pathological upgrading to CC.

Citing Articles

Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.

Lei L, Zhang L, Zheng Y, Ma W, Liu F, Li D BMC Cancer. 2024; 24(1):575.

PMID: 38724921 PMC: 11080298. DOI: 10.1186/s12885-024-12342-2.

References

Stolnicu S, Hoang L, Soslow R . Recent advances in invasive adenocarcinoma of the cervix. Virchows Arch. 2019; 475(5):537-549. PMC: 6864265. DOI: 10.1007/s00428-019-02601-0. View

Cuburu N, Schiller J . Moving forward with human papillomavirus immunotherapies. Hum Vaccin Immunother. 2016; 12(11):2875-2880. PMC: 5137534. DOI: 10.1080/21645515.2016.1199302. View

Gu M, Zhai Z, Huang L, Zheng W, Zhou Y, Zhu R . Pre-treatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer. Breast Cancer. 2015; 23(5):752-60. DOI: 10.1007/s12282-015-0635-6. View

Costa S, De Nuzzo M, Rubino A, Rambelli V, Marinelli M, Santini D . Independent determinants of inaccuracy of colposcopically directed punch biopsy of the cervix. Gynecol Oncol. 2003; 90(1):57-63. DOI: 10.1016/s0090-8258(03)00202-6. View

Wentzensen N, Walker J, Gold M, Smith K, Zuna R, Mathews C . Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2014; 33(1):83-9. PMC: 4268255. DOI: 10.1200/JCO.2014.55.9948. View

Hutchcraft M, Miller R . Bleeding from Gynecologic Malignancies. Obstet Gynecol Clin North Am. 2022; 49(3):607-622. DOI: 10.1016/j.ogc.2022.02.022. View

Adams T, Denny L . Abnormal vaginal bleeding in women with gynaecological malignancies. Best Pract Res Clin Obstet Gynaecol. 2016; 40:134-147. DOI: 10.1016/j.bpobgyn.2016.09.014. View

Goubran H, Stakiw J, Radosevic M, Burnouf T . Platelet-cancer interactions. Semin Thromb Hemost. 2014; 40(3):296-305. DOI: 10.1055/s-0034-1370767. View

Wang J, Wang Y, Huang Y, Wang H, Zhu J, Shi J . Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer. Dose Response. 2019; 17(3):1559325819874199. PMC: 6734622. DOI: 10.1177/1559325819874199. View

10.

Elit L . Cervical cancer in the older woman. Maturitas. 2014; 78(3):160-7. DOI: 10.1016/j.maturitas.2014.04.018. View

11.

Giannella L, Fodero C, Boselli F, Mfuta K, Rubino T, Prandi S . Age-related changes in the diagnostic assessment of women with severe cervical lesions. Climacteric. 2015; 18(4):617-23. DOI: 10.3109/13697137.2015.1005592. View

12.

Castanon A, Landy R, Cuzick J, Sasieni P . Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study. PLoS Med. 2014; 11(1):e1001585. PMC: 3891624. DOI: 10.1371/journal.pmed.1001585. View

13.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

14.

Berman T, Schiller J . Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer. 2017; 123(12):2219-2229. DOI: 10.1002/cncr.30588. View

15.

Gasparyan A, Ayvazyan L, Mikhailidis D, Kitas G . Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des. 2011; 17(1):47-58. DOI: 10.2174/138161211795049804. View

16.

Alrajjal A, Pansare V, Choudhury M, Khan M, Shidham V . Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System. Cytojournal. 2021; 18:16. PMC: 8326095. DOI: 10.25259/Cytojournal_24_2021. View

17.

Gibb R, Martens M . The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol. 2011; 4(Suppl 1):S2-S11. PMC: 3101960. View

18.

Du L, Xu B, Huang C, Zhu L, He N . Menopausal Symptoms and Perimenopausal Healthcare-Seeking Behavior in Women Aged 40-60 Years: A Community-Based Cross-Sectional Survey in Shanghai, China. Int J Environ Res Public Health. 2020; 17(8). PMC: 7215590. DOI: 10.3390/ijerph17082640. View

19.

Perkins R, Guido R, Castle P, Chelmow D, Einstein M, Garcia F . 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020; 24(2):102-131. PMC: 7147428. DOI: 10.1097/LGT.0000000000000525. View

20.

Massad L, Einstein M, Huh W, Katki H, Kinney W, Schiffman M . 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013; 121(4):829-846. DOI: 10.1097/AOG.0b013e3182883a34. View